DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

* Revenues grew 14% reaching $1.779M in Q2/26, beating management projections * Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from 'WGRX' to 'MEDS' on NASDAQ Capital Markets * $6.5 million new funding in June 2026 provided capital to support corporate turnaround * Pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate patent protected blockchain, biometrics and pharmaceutical-adjunct products intellectual properties to deliver the "Health Lives Here" consumer app, in partnership with NFL Alumni Health (NFLAH), to deliver an effective healthcare experience to patients in rural communities via local independent pharmacies * 1:50 reverse split in May 2026 implemented to partially address NASDAQ delisting risk * Holders of 1,533,930 common shares, representing ~49% of shares outstanding, have entered into lock-up agreements for at least an additional ninety (90) days * Dream Bowl Meme Coin I token distribution Payment Date set as September 9, 2026 with ratio of 50 tokens per common share owned as of end of business August 7, 2026 * KareRx joint venture added Electronic Benefits Verification (EBV) and access to 200,000 patient lives that began to provide material revenue to rebranded Corexa Pharmacy * Neuritek Therapeutics, Inc. pending acquisition was terminated in May 2026